ArticleCancer cell2019

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.

Nicholas F Kuhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.